List of Contents

Medical Affairs Outsourcing Market Size, Share, and Trends 2024 to 2034

Medical Affairs Outsourcing Market (By Service: Medical Monitoring, Medical Writing & Publishing, Medical Information, Medical Science Liaisons and Others; By Industry: Medical Devices, Pharmaceutical, Biopharmaceutical) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033

  • Last Updated : February 2024
  • Report Code : 1113
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Medical Affairs Outsourcing Market, By Services

7.1. Medical Affairs Outsourcing Market, by Services Type, 2024-2033
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Medical Affairs Outsourcing Market, By Industry

8.1. Medical Affairs Outsourcing Market, by Industry, 2024-2033
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.2. Market Revenue and Forecast, by Industry (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.4.2. Market Revenue and Forecast, by Industry (2021-2033)

Chapter 10. Company Profiles

10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

 

12.1. About Us
12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global medical affairs outsourcing market size was valued at USD 1.82 billion in 2023 and is predicted to reach over USD 3.66 billion by 2033.

The global medical affairs outsourcing market is expected to grow at a CAGR of 7.3% over forecast period 2024 to 2033.

In 2023, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of the total market

Pharmaceutical industry segment conquered the global market by accounting prominent share more than 52.86% of the total revenue generated by market in 2023.

Some of the major participants contending in the market arena are IQVIA Holdings Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Syneos Health Inc., ICON plc, ZEINCRO Group, Pharmaceutical Product Development, LLC, Wuxi Clinical Development, Inc., Indegene Inc and SGS SA.

Global medical affairs outsourcing market is propelled by escalating research and developments undertakings along with growing spending in the healthcare sector across the globe. Further rising emphasis on CROs and CMOs is supporting the market growth across different economies in the world.

North America occupied for the prominent revenue chunk of the total gathered by global medical affairs outsourcing market in 2023 across various segments.

Asia Pacific is projected to record the utmost compounded annual growth throughout the estimate period due to contributing factors such as accessibility of low-cost labor and intensifying cases of regulatory filings.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
* Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us